Elizabeth Ostrander

Beth is a Principal Scientist in Analytical Research and Development at Pfizer where she is responsible for characterizing nucleic acid therapeutics using Next-Generation Sequencing technologies. Prior to joining Pfizer in 2021, Beth worked at the clinical sequencing software company PerianDx (now Velsera) as a Genomics and Product Specialist for two years. Beth holds a PhD in Human and Statistical Genetics granted in 2019 from Washington University in St. Louis.